MENU
+Compare
MCRB
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$19.36
Change
+$0.56 (+2.98%)
Capitalization
169.49M

MCRB Seres Therapeutics Inc Forecast, Technical & Fundamental Analysis

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States... Show more

Industry: #Biotechnology
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MCRB with price predictions
Sep 05, 2025

MCRB sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MCRB moved above the 200-day moving average on August 27, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 11, 2025. You may want to consider a long position or call options on MCRB as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MCRB advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where MCRB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MCRB moved out of overbought territory on August 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where MCRB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MCRB turned negative on September 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

MCRB broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MCRB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.144) is normal, around the industry mean (20.126). P/E Ratio (0.000) is within average values for comparable stocks, (52.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.088). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.792) is also within normal values, averaging (327.236).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of novel treatments for diseases related to the human microbiome

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMBLF17.620.29
+1.69%
Brambles, Ltd.
LBSR0.05N/A
+0.73%
Liberty Star Uranium & Metals Corp.
FUWAY28.50N/A
N/A
Furukawa Electric Co., Ltd.
NPACF18.10N/A
N/A
Quadient SA
CXGEF0.18N/A
N/A
Computer & Technologies Holdings Ltd.

MCRB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+2.98%
RIGL - MCRB
38%
Loosely correlated
+3.02%
MTVA - MCRB
33%
Poorly correlated
+0.44%
OTLK - MCRB
32%
Poorly correlated
+5.27%
ATXS - MCRB
29%
Poorly correlated
+7.43%
HALO - MCRB
27%
Poorly correlated
+2.08%
More